Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
Christina Sternberg(University of Veterinary Medicine Vienna), Lukas Kenner(University of Veterinary Medicine Vienna)
Cited by 0
Related Papers
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
|Nature Medicine|2012|125
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
|Frontiers in Oncology|2020|113
Synergistic cross‐talk of hedgehog and interleukin‐6 signaling drives growth of basal cell carcinoma
|International Journal of Cancer|2018|29
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
|Molecular Cancer|2025|0